Effects of treatment with muramyl dipeptide on resistance to Mycobacterium leprae and Mycobacterium marinum infection in mice (Q54499924)

30 May 2018

title

Effects of treatment with muramyl dipeptide on resistance to Mycobacterium leprae and Mycobacterium marinum infection in mice (English)

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

3 October 2023

main subject

Mycobacterium marinum

0 references

0 references

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

3 October 2023

author name string

J. L. Krahenbuhl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343295

3 October 2023

R. C. Humphres

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343295

3 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6343295

3 October 2023

publication date

1 April 1983

1 reference

30 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0162310983900486?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

https://api.elsevier.com/content/article/PII:0162310983900486?httpAccept=text/plain

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

3 October 2023

1 reference

30 May 2018

volume

5

1 reference

30 May 2018

issue

4

1 reference

30 May 2018

page(s)

329-339

1 reference

30 May 2018

Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Modulation of the immune response by a synthetic adjuvant and analogs

3 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide

3 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Corynebacterium parvum: a Synonym for Propionibacterium acnes?

3 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-l-alanyl-d-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice

3 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

3 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

The macrophage, target cell of the synthetic adjuvant muramyl dipeptide

3 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Failure of synthetic muramyl dipeptide to increase antibacterial resistance

3 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.

3 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide

3 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Resistance to Mycobacterium leprae in Mice Infected with Toxoplasma gondii and Besnoitia jellisoni.

3 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Influence of MDP and of some analogous synthetic glycopeptides on the in vitro mouse spleen cell viability and immune response to sheep erythrocytes

3 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Inhibitory and stimulatory effects of a synthetic glycopeptide (MDP) on the in vitro PFC response: Factors affecting the response

3 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components

3 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

The influence of immunologically committed lymphoid cells on macrophage activity in vivo

3 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Analogy of Mycobacterium marinum Disease to Mycobacterium leprae Infection in Footpads of Mice

3 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor

3 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse

3 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Macrophage activation by bacterial cell walls and related synthetic compounds

3 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide

3 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

3 October 2023

Identifiers

1 reference

30 May 2018

1 reference

30 May 2018